KB Financial Partners’s Integra LifeSciences IART Stock Holding History

KB Financial Partners’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$4K	Hold	110	–	–	﹤0.01%	446
2023 Q2	$5K	Hold	110	–	–	﹤0.01%	433
2023 Q1	$6K	Hold	110	–	–	﹤0.01%	413
2022 Q4	$6K	Sell	110 -3	-3%	-$153	﹤0.01%	406
2022 Q3	$5K	Hold	113	–	–	﹤0.01%	413
2022 Q2	$6K	Sell	113 -61	-35%	-$3.66K	﹤0.01%	398
2022 Q1	$11K	Hold	174	–	–	﹤0.01%	398
2021 Q4	$12K	Buy	+174	New	+$11.8K	﹤0.01%	411
2021 Q3	–	Sell	-174	Closed	-$12K	–	344
2021 Q2	$12K	Sell	174 -43	-20%	-$3.04K	﹤0.01%	388
2021 Q1	$15K	Buy	+217	New	+$14.7K	0.01%	395

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KB Financial Partners's IART Position: Q3 2023 in Review

KB Financial Partners held its Integra LifeSciences (IART) position steady in Q3 2023 at 110 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #446.

KB Financial Partners first reported a position in IART in Q1 2021 and has held it in 10 quarters since. The position peaked at $15K in Q1 2021. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

KB Financial Partners held 110 shares of Integra LifeSciences worth $4K as of Q3 2023.
KB Financial Partners left its Integra LifeSciences share count unchanged in Q3 2023.
Integra LifeSciences made up ﹤0.01% of KB Financial Partners's portfolio in Q3 2023, its #446 holding.
KB Financial Partners first reported a position in Integra LifeSciences in Q1 2021 and has held it in 10 quarters since.
KB Financial Partners's Integra LifeSciences position peaked at $15K in Q1 2021.
262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.